Cell Therapy—a Basic Science Primer for the Sports Medicine Clinician
- 4 Downloads
Purpose of Review
The emergence of cell-based therapies has brought much excitement to the field of orthopedic sports medicine. However, the significant inconsistency of reporting has led to the poor understanding, misinformation, and false expectations for patients and clinicians alike. In this paper, we aim to clarify the available cell-therapy treatments and summarize some of the latest research.
Although this technology is in early development, our understanding of cell biology has grown significantly over the last decade. Furthermore, it is becoming evident that tissue specificity may play a significant role in determining the effectiveness and overall clinical benefit attributed to cell therapy.
Cell therapy is an emerging field with tremendous potential for clinically significant benefit. However, in its current state, clinical application of these treatments is limited by federal regulations, variability in formulation, and limited understanding of the biologic activity of various cell formulations.
KeywordsCell therapy Bioengineering Regenerative medicine Orthobiologics Sports medicine Orthopedics
Compliance with Ethical Standards
Conflict of Interest
Dr. Scott Rodeo and Mr. Bijan Dehghani declare that they have no conflict of interest.
Dr. Scott Rodeo reports personal fees from Ortho RTI and personal fees from Flexion Therapeutics, Inc. outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 4.•• Food and Drug Administration USDoHaHS. Regulatory Considerations for Human Cells, Tissues and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. In: Research USDoHaHSFaDACfBEa, ed; 2017. This reference lays the foundation for regulatory environment surrounding cell therapy in the United States. Google Scholar
- 10.Friedenstein AJ. Johan N.M. Heersche, John A. Kanis editors. Osteogenic stem cells in bone marrow. In: Bone and Mineral Research, Elsevier; 1990.Google Scholar
- 15.da Silva ML, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5–6):419–27.Google Scholar
- 25.Pogozhykh O, Prokopyuk V, Figueiredo C, Pogozhykh D. Placenta and placental derivatives in regenerative therapies: experimental studies, history, and prospects. Stem Cells Int. 2018;2018.Google Scholar
- 26.Kamei N, Atesok K, Ochi M. The use of endothelial progenitor cells for the regeneration of musculoskeletal and neural tissues. Stem Cells Int. 2017;2017.Google Scholar
- 31.Peng XG, Bai Y, James JR, Shlapak DP, Ju S. Transplanted endothelial progenitor cells improve ischemia muscle regeneration in mice by diffusion tensor MR imaging. Stem Cells Int. 2016;2016.Google Scholar
- 32.Liotta F, Annunziato F, Castellani S, Boddi M, Alterini B, Castellini G, et al. Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia―the SCELTA trial―. Circ J. 2018;82(6):1688–98.PubMedCrossRefPubMedCentralGoogle Scholar
- 35.•• Rafii S, Butler JM, Ding BS. Angiocrine functions of organ-specific endothelial cells. Nature. 2016;529(7586):316. This reference is the first to describe a tissue specific set of growth factors referred to as Angiocrine factors. This brings to light the importance, and potential therapeutic application, of tissue specific cells for promoting regeneration and healing.–25.PubMedPubMedCentralCrossRefGoogle Scholar
- 39.Gholobova D, Gerard M, Terrie L, Desender L, Shansky J, Vandenburgh H, Thorrez L. Coculture method to obtain endothelial networks within human tissue-engineered skeletal muscle. In: Myogenesis. New York: Humana press; 2019. (pp. 169-183).Google Scholar
- 41.• Lee KJ, Clegg PD, Comerford EJ, Canty-Laird EG. Ligament-derived stem cells: Identification, characterization, and therapeutic application. Stem Cells Int. 2017;2017. This reference reports the ligament specific stem cells as a unique class of cells with the potential of tissue maintenance and regeneration in structures initially thought to have no intrinsic healing potential. Google Scholar
- 42.• Gamer LW, Shi RR, Gendelman A, Mathewson D, Gamer J, Rosen V. Identification and characterization of adult mouse meniscus stem/progenitor cells. Connect Tissue Res. 2017;58(3–4):238–45 This reference identifies a population of cells with stem like capacity in meniscal tissue. Providing a new avenue for researching meniscus regeneration and healing. PubMedCrossRefGoogle Scholar
- 51.•• Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. JBJS. 2017;99(20):1769–79 This reference cumulates the reported data on platelet-rich-plasma, its composition, and preparation protocols. Using this data, they highlight the significant inconsistencies contributing to the wide spread variability associated with the use of platelet-rich-plasma. This paper also suggests reporting measures that should be followed for future studies using platelet-rich-plasma to allow for consistent and accurate data. CrossRefGoogle Scholar
- 53.• Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226–33. This reference reports on the clinical benefits of using platelet-rich-plasma for tendinopathy. While platelet-rich-plasma is used for many indications, only tendinopathy has strong clinical data to support its use. PubMedCrossRefGoogle Scholar
- 55.O'Shaughnessey K, Matuska A, Hoeppner J, Farr J, Klaassen M, Kaeding C, et al. Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors. J Orthop Res. 2014;32(10):1349–55.PubMedPubMedCentralCrossRefGoogle Scholar
- 62.•• Patterson TE, Boehm C, Nakamoto C, Rozic R, Walker E, Piuzzi NS, et al. The Efficiency of Bone Marrow Aspiration for the Harvest of Connective Tissue Progenitors from the Human Iliac Crest. J Bone Joint Surg Am. 2017;99(19):1673–82. This reference reports the miniscule concentration of “stem cells” present from bone marrow aspirate. Although incorrect, many clinicians believe bone marrow aspirate to be robust in stem cells, however, the actual concentration is significantly lower than what is believed to be clinically effective. These results could significantly influence the use of bone marrow aspirate clinically. PubMedPubMedCentralCrossRefGoogle Scholar
- 63.Qadan MA, Piuzzi NS, Boehm C, Bova W, Moos M Jr, Midura RJ, et al. Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue. Cytotherapy. 2018;20(3):343–60.PubMedPubMedCentralCrossRefGoogle Scholar
- 68.Uchida R, Horibe S, Nakamura N. Stem cell-based therapy in anterior cruciate ligament repair. Annals of Joint. 2017;30:2(11).Google Scholar
- 72.• Piontek T, Ciemniewska-Gorzela K, Naczk J, Jakob R, Szulc A, Grygorowicz M, et al. Complex meniscus tears treated with collagen matrix wrapping and bone marrow blood injection: a 2-year clinical follow-up. Cartilage. 2016;7(2):123–39. In this reference they demonstrate how complex meniscal tears, otherwise thought to be irreparable, have shown positive clinical outcomes when the repair is augmented with acellular collagen scaffold. This goes against the dogma of meniscus treatment, suggesting a potential for the repair of complex meniscal lesions. PubMedCrossRefPubMedCentralGoogle Scholar
- 73.• Nakagawa Y, Muneta T, Kondo S, Mizuno M, Takakuda K, Ichinose S, et al. Synovial mesenchymal stem cells promote healing after meniscal repair in microminipigs. Osteoarthritis Cartilage. 2015;23(6):1007–17. In the paper, they demonstrate how meniscal injury causes an influx of mesenchymal stem (stromal) cells with the potential for healing. Not only does this suggest an intrinsic healing mechanism, it also highlights a potential cell source for therapy. PubMedCrossRefPubMedCentralGoogle Scholar
- 77.• Kim YS, Sung CH, Chung SH, Kwak SJ, Koh YG. Does an injection of adipose-derived mesenchymal stem cells loaded in fibrin glue influence rotator cuff repair outcomes? A clinical and magnetic resonance imaging study. Am J Sports Med. 2017;45(9):2010–8. This reference reports on the use of adipose derived mesenchymal stem (stromal) cells in conjunction with fibrin based glue for rotator cuff repair, giving a possible answer to the question of delivery vehicle for cell therapy. This also suggest a role for cell therapy in rotator cuff repair. PubMedCrossRefPubMedCentralGoogle Scholar
- 78.Hernigou P, Lachaniette CH, Delambre J, Zilber S, Duffiet P, Chevallier N, et al. Biologic augmentation of rotator cuff repair with mesenchymal stem cells during arthroscopy improves healing and prevents further tears: a case-controlled study. Int Orthop. 2014;38(9):1811–8.PubMedCrossRefPubMedCentralGoogle Scholar
- 83.• Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O’Connor MI. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2017;45(1):82–90. This reference is the only placebo controlled, single blinded study assessing the clinical efficacy of using bone marrow aspirate for the treatment of OA. Not only does it provide a process for performing this type of study, they also demonstrate improvements in pain scores. This suggest a role of bone marrow aspirate in knee OA therapy. PubMedCrossRefGoogle Scholar
- 84.• Gobbi A, Whyte GP. One-stage cartilage repair using a hyaluronic acid–based scaffold with activated bone marrow–derived mesenchymal stem cells compared with microfracture: five-year follow-up. Am J Sports Med. 2016;44(11):2846–54. This study reports the added advantage of using bone-marrow derived mesenchymal stem (stromal) cells in conjunction with hyaluronic acid based scaffolds in the treatment of cartilage defect. This shows a sustained benefit of this therapy compared to current treatment options suggesting a potential for therapies with long-term clinical benefit. PubMedCrossRefGoogle Scholar